hydroxyl radical has been researched along with indapamide in 1 studies
| Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (indapamide) | Trials (indapamide) | Recent Studies (post-2010) (indapamide) |
|---|---|---|---|---|---|
| 10,147 | 26 | 3,657 | 1,089 | 350 | 264 |
| Protein | Taxonomy | hydroxyl radical (IC50) | indapamide (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.918 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, D; Dong, Y; Koch, M; Moezzi, D; Yong, VW | 1 |
1 other study(ies) available for hydroxyl radical and indapamide
| Article | Year |
|---|---|
Combination of Hydroxychloroquine and Indapamide Attenuates Neurodegeneration in Models Relevant to Multiple Sclerosis.
Topics: Animals; Brain; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Hydroxyl Radical; Indapamide; Mice; Mice, Inbred C57BL; Microglia; Microscopy, Confocal; Microscopy, Fluorescence; Multiple Sclerosis; Neurons; Neuroprotective Agents; Spinal Cord | 2021 |